We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
19 hedge funds and large institutions have $29.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
12% more funds holding
Funds holding: 17 → 19 (+2)
11% more capital invested
Capital invested by funds: $26.6M → $29.7M (+$3.03M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
3
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.14M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$141K |
| 3 |
Neuberger Berman Group
New York
|
+$41.8K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$34K |
| 5 |
KA
Klingman & Associates
New York
|
+$16.3K |
Top Sellers
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
-$8.29M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.48M |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$2.35M |
| 4 |
PA
Perceptive Advisors
New York
|
-$674K |
| 5 |
Goldman Sachs
New York
|
-$86K |
